Home » International News » 2011 » September » September 29, 2011

New BIOTRONIK Home Monitoring® Quick View Report Enhances Efficiency of Cardiac Device Patient Management

September 29, 2011 - Berlin, Germany

BIOTRONIK, a worldwide leader in manufacturing cardiac medical devices and pioneer of remote patient management solutions, today announced the introduction of a new online Quick View report designed to deliver even greater efficiency when managing patients using BIOTRONIK Home Monitoring® technology.

BIOTRONIK Home Monitoring - CardioMessenger Handheld an Stationary Devices (Photo: Business Wire)

BIOTRONIK Home Monitoring - CardioMessenger Handheld an Stationary Devices (Photo: Business Wire)

“The comprehensive, intuitive new charts and rolling six-month trend graphs provided by the Quick View report allow me to more quickly and effectively check each patient's condition online”, explained Dr. Carsten Stoepel from the Lukas Hospital in Neuss, Germany. “Combined with the unique automatic daily transmissions offered by BIOTRONIK Home Monitoring®, I can easily and efficiently conduct remote follow-ups at any time, from anywhere — which is especially important following a critical event.”

BIOTRONIK Home Monitoring® consists of an antenna that is integrated into a cardiac device such as a pacemaker or an implantable cardioverter-defibrillator (ICD), which then continuously and automatically transmits clinical and device status data using the global cellular phone network, enabling physicians to remotely monitor each patient by accessing a secure, password-protected website from any location. The new Quick View report is readily accessible via the user’s secure website and provides clinicians with a quick — yet comprehensive — review of the most relevant and the most recent patient and device status information.

The Quick View report is designed to improve the speed at which clinicians can find and review patient device data by providing a very intuitive, user-friendly presentation of the information at the simple click of a button. The easy-to-navigate Quick View report is immediately available with all premium BIOTRONIK cardiac devices, namely the Evia pacemakers and the entire Lumax family of ICDs and cardiac resynchronization therapy (CRT) devices equipped with BIOTRONIK Home Monitoring®.

About BIOTRONIK Home Monitoring®

BIOTRONIK Home Monitoring® is the first and only remote patient management system with FDA and CE approvals for safe reduction of in-office follow-ups and for early detection of clinically relevant events, leading to earlier intervention, based on results of the TRUST landmark trial1-2. The system is unique because it allows continuous automatic wireless remote monitoring of patient status and device status with daily updates, all independent from any patient interaction. BIOTRONIK Home Monitoring® has pioneered advances in remote patient management since its first clinical application in the year 2000. Today, BIOTRONIK Home Monitoring® is extensively used in a growing number of patients in more than 3,800 clinics and 55 countries worldwide.


As one of the world’s leading manufacturers of cardiovascular medical devices, with several million devices implanted, BIOTRONIK is represented in over 100 countries by its global workforce of over 5,600 employees. Known for having its finger on the pulse of the medical community, BIOTRONIK assesses the challenges physicians face, and provides the best solutions for all phases of patient care, ranging from diagnosis to treatment to patient management. Quality, innovation and reliability define BIOTRONIK and its growing success, and deliver confidence and peace of mind to physicians and their patients worldwide.

More information:

Upon publication, please provide us with a copy.

1 Varma et al., Circulation 2010, 122, 325–332

2 Varma et al., Circ Arrhythm Electrophysiol 2010, 3:428–436

Photos/Multimedia Gallery Available:


CONTACTS : BIOTRONIK SE & Co. KG Sandy Hathaway Senior Director, Global Communications Tel. +49 (0) 30 68905 1602 Email:

Source: Business Wire India


Comment on this story